| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/08/2004 | DE10259200A1 Adhäsionshemmung von keratinophilen Pilzen Adhesion inhibition of fungi keratinophilic |
| 07/08/2004 | CA2789415A1 Macrolides |
| 07/08/2004 | CA2510445A1 Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents |
| 07/08/2004 | CA2510229A1 Production of alvac on avian embryonic stem cells |
| 07/08/2004 | CA2510189A1 Trivalent vaccine with maternal antibody transfer via the milk |
| 07/08/2004 | CA2510069A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | CA2510027A1 Piperidine derivatives useful as ccr5 antagonists |
| 07/08/2004 | CA2509645A1 Antibiotics containing borinic acid complexes and methods of use |
| 07/08/2004 | CA2509423A1 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | CA2509419A1 Macrolides |
| 07/07/2004 | EP1435359A1 A process for the purification of roxithromycin |
| 07/07/2004 | EP1435357A2 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434990A2 Method for identifying compounds the specifically deplete mast cells |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434882A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 07/07/2004 | EP1434863A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS |
| 07/07/2004 | EP1434862A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434859A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 07/07/2004 | EP1434858A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 07/07/2004 | EP1434802A1 Human tissue factor antibodies |
| 07/07/2004 | EP1434799A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434794A2 Fragments of heat shock proteins and their use |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434786A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434779A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434761A1 Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434603A2 Method of treatment using ligand-immunogen conjugates |
| 07/07/2004 | EP1434602A2 Cpg formulations and related methods |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434572A2 Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles |
| 07/07/2004 | EP1232249B1 Duck pneumovirus and corresponding vaccines |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1212093B1 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 07/07/2004 | EP1181393A4 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 07/07/2004 | EP1082093B1 Anti-germ attachment - composition |
| 07/07/2004 | EP0928198B1 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 07/07/2004 | EP0907373B1 Use of synergistic compositions of il-12 and ifn-alpha for the treatment of infectious diseases |
| 07/07/2004 | CN1511164A Peptides presented by cells |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511156A 碳青霉烯化合物 Carbapenem compounds |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease |
| 07/07/2004 | CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511053A HSA-free formulations of interferon-Beta |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 07/07/2004 | CN1511035A Gatifloxacin pentahydrate |
| 07/07/2004 | CN1510147A Determination of alpha-N-acetamino galactosidase activity |
| 07/07/2004 | CN1510144A Establishment and use of hfg 12 prothrombin double chain RNA and oligonucleotide |
| 07/07/2004 | CN1510137A Gene identification |
| 07/07/2004 | CN1510130A Attenuated cattle viral diarrhoea virus |
| 07/07/2004 | CN1510032A Oxazolidone compound, preparing method and use thereof |
| 07/07/2004 | CN1509762A Use of slaphylococcus aureus enterotoxins in preparing drugs for treating or preventing A1DS |
| 07/07/2004 | CN1509755A Chinese medicine for treating hepatitis B and preparing method thereof |
| 07/07/2004 | CN1509741A Chinese medicinal preparation for preventing herpes virus and preparing method thereof |
| 07/07/2004 | CN1509736A Specific medicinal composition for treating hepatitis B |
| 07/07/2004 | CN1509724A Propolis and preparing method thereof |
| 07/07/2004 | CN1509715A Rifaximin drop |
| 07/07/2004 | CN1156488C Derivative of micronomycine and its preparing process and medical application |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156471C 5-phridyl-1,3-azole compounds, process for producing the same and use thereof |
| 07/07/2004 | CN1156461C Improved aqueous solubility pharmaceutical formulations |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156449C Process for preparing N-(amino-4,6-dihalopyrimidine) formamide |
| 07/07/2004 | CN1156448C Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity |
| 07/07/2004 | CN1156302C Ointment capable of quick sterilizing AIDS, veneral virus and spermatozoa and preparation process thereof |
| 07/07/2004 | CN1156299C Health-care tea as cigarette companion and its preparation method |
| 07/07/2004 | CN1156297C Medicine for treating hepatitis B |
| 07/06/2004 | US6759544 Antimicrobially active acesulfame complexes, process for their preparation and their use |
| 07/06/2004 | US6759538 Substituted diphenyl heterocycles useful for treating HCV infection |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759516 Methods of identifying antigen gene sequences |
| 07/06/2004 | US6759513 Death domain containing receptors |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759423 4-Hydroxyisothiazole compounds |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759213 Haemophilus adhesion proteins |
| 07/06/2004 | US6759209 For antibiotic drug screening |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |
| 07/06/2004 | US6759051 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol |
| 07/06/2004 | US6759036 Fibrocyte-base vaccine formulations |
| 07/06/2004 | CA2278759C Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 07/06/2004 | CA2235902C Method for treating protozoal infections |
| 07/06/2004 | CA2217417C 9-n-ethenyl derivatives of 9(s)-erythromycylamine |
| 07/06/2004 | CA2140361C Composition and methods for decreasing muscle breakdown |
| 07/06/2004 | CA2119556C Substituted aryl- and heteroaryl-phenyloxazolidinones |
| 07/01/2004 | WO2004055210A1 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same |